Urological Research

, Volume 33, Issue 4, pp 247–253

Bone mineral content in calcium renal stone formers

Invited Review

Abstract

Idiopathic renal calcium stone disease often presents with reduced bone mineral content. Investigations using non-invasive methods for the measurement of bone mineral content (single and dual-photon absorptiometry, dual-energy x-ray absorptiometry, quantitative computed tomodensitometry) show a slight decrease in skeletal mineral content of idiopathic renal stone formers (RSFs).The alterations in bone mineral content in RSFs have different explanations: prostaglandin-mediated bone resorption, subtle metabolic acidosis and 1–25 vitamin D disorders. Bone mineral content is worsened by insufficient dietary calcium leading to a negative calcium balance.

Keywords

Calcium stone disease Bone mineral density Hypercalciuria Dietary calcium Hyperparathyroidism 

References

  1. 1.
    Albright F, Aub JC, Bauer W (1934) Hyperparathyroidism: a common and polymorphic condition as illustrated by 17 proven cases from one clinic. JAMA 102: 1276Google Scholar
  2. 2.
    Alhava EM, Juuti M, Karjalainen P (1976) Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 10: 154PubMedGoogle Scholar
  3. 3.
    Anderson J, Lee HA, Tomlinson RWS (1976) Some metabolic aspects of idiopathic hypercalciuria. Nephron 4: 129Google Scholar
  4. 4.
    Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J (1985) Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrol Metab 11: 19Google Scholar
  5. 5.
    Bataille P, Bouillon R, Fournier A, Renaud H, Gueris J, Idrissi A (1987) Increased plasma concentrations of total and free 1,25-(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. Contr Nephrol 58: 137Google Scholar
  6. 6.
    Bataille P, Achard JM, Fournier A, Boudail B, Westeel PF, Esper N, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Laval A, Jeantet MA, Bouillon R, Sebert JL (1991) Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39: 1193PubMedGoogle Scholar
  7. 7.
    Bataille P, Marie A, Ghazali A, Cohen Solal ME, Steiniche T, Brazier M, Gueris J, Sebert JL, Fournier A (1996) Histological and biochemical study of bone turnover in calcium stone formers (CSF) with fasting hypercalciuria and osteopenia. In: Pak CYC, Resnick MI, Preminger GM (ed) Urolithiasis 1996. Millet, Dallas, p 1Google Scholar
  8. 8.
    Bordier P, Ryckewart A, Gueris J (1977) On the pathogenesis of so-called hypercalciuria. Am J Med 63: 398CrossRefPubMedGoogle Scholar
  9. 9.
    Borghi L, Meschi T, Guerra A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A (1991) Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 146: 1334PubMedGoogle Scholar
  10. 10.
    Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H (1980)The importance of circulating 1,25(OH)2D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N Engl J Med 302: 421Google Scholar
  11. 11.
    Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311: 73PubMedGoogle Scholar
  12. 12.
    Buck AC, Lote CJ, Sampson WF (1983) The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 129: 421PubMedGoogle Scholar
  13. 13.
    Coe FL, Kavalach AG (1974) Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291: 1344PubMedGoogle Scholar
  14. 14.
    Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM (1982) Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72: 25CrossRefPubMedGoogle Scholar
  15. 15.
    Cormier C (1995) Markers of bone metabolism. Curr Opin Rheumatol 7: 243PubMedGoogle Scholar
  16. 16.
    Dalen N, Hjern B (1974) Bone mineral content in patients with primary hyperparathyroidism without radiological evidences of skeletal changes. Acta Endocrinol 75: 297PubMedGoogle Scholar
  17. 17.
    Dent CE, Hartland BV, Hicks J, Sykes ED (1961) Calcium intake with primary hyperparathyroidism. Lancet 2: 336CrossRefPubMedGoogle Scholar
  18. 18.
    Diaz Perez de Madrid J, Munoz Torres M, Garcia de Vinuesa MJ, Mijan JL, Escobar Jimenez F, Zuluaga A (1989) Parathormone, cyclic AMP, 1,25 dihydroxyvitamin D and osteocalcin in hypercalciuric renal lithiasis. Arch Esp Urol 42: 129PubMedGoogle Scholar
  19. 19.
    Filipponi P, Mannarelli C, Pacifici R, Grossi E, Moretti I, Tini S, Carloni C, Blass A, Morucci P, Hruska KA, Avioli LV (1988) Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 43: 61PubMedGoogle Scholar
  20. 20.
    Forland M, Strandjord NM, Paloyan E, Cox A (1968) Bone density studies in primary hyperparathyroidism. Arch Intern Med 122: 236CrossRefPubMedGoogle Scholar
  21. 21.
    Frost HM (1983) The skeletal intermediary organization: a review. Metab Bone Dis Rel Res 4: 281Google Scholar
  22. 22.
    Fuss M, Gillet C, Simom J, Vandewalle J-C, Schoutens A, Bergmann P (1983) Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 9: 32PubMedGoogle Scholar
  23. 23.
    Fuss M, Pepersack T, Bergman P, Hurard T, Simon J, Corvilain J (1990) Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol 65: 560PubMedGoogle Scholar
  24. 24.
    Fuss M, Pepersack T, Van Geel J, Corvilain J, Vandewalle JC, Bergmann P, Simon J (1990) Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 46: 9PubMedGoogle Scholar
  25. 25.
    Fuss M, Pepersack T, Corvilain J, Bergmann P, Simon J, Body JJ (1991) Calcitonin secretion in idiopathic renal stone formers. J Bone Miner Res 6: 35PubMedGoogle Scholar
  26. 26.
    Ghazali A, Fuentes V, Deisaint C, Westeel A, Brazier M, Prin L, Fournier A (1997) Low bone mineral density and peripheral monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82: 32CrossRefPubMedGoogle Scholar
  27. 27.
    Goldfarb S (1988) Dietary factors in the pathogenesis and prophylaxis of nephrolithiasis. Kidney Int 34: 544PubMedGoogle Scholar
  28. 28.
    Hess B, Casez J-P, Takkinen R, Ackermann D, Jaeger P (1993) Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers. Impact of nutrition. Am J Nephrol 13: 18PubMedGoogle Scholar
  29. 29.
    Hisazumi H, Katsumi T (1970) A study of the mineral contents of the bone by x-rays in patients with urolithiasis. Jpn J Urol 61: 266Google Scholar
  30. 30.
    Hosgkin DJ, Chamberlain MJ, Fremlin JH (1972) Changes in total body calcium content in primary hyperparathyroidism. Clin Sci 43: 627PubMedGoogle Scholar
  31. 31.
    Jaeger P, Lippuner K, Casez J-P, Hess B, Ackermann D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9: 1525PubMedGoogle Scholar
  32. 32.
    Jungers P, Houillier P, Liote F, De Groote D, Labrunie M, Daudon M, Descamps-Latscha B (1996) Imbalance between monocyte-derived cytokines and their specific inhibitors in idiopathic hypercalciuria. In: Pak CYC, Resnick MI, Preminger GM (eds) Urolithiasis 1996.. Millet, Dallas, p 68Google Scholar
  33. 33.
    Kanis JA, Melton LJIII, Christiansen C, Johnson CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137PubMedGoogle Scholar
  34. 34.
    Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1,25(OH)2D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59: 756PubMedGoogle Scholar
  35. 35.
    Katayama Y, Umekawa T, Ishikawa Y, Kodama M, Takada M, Katoh Y, Kataoka K, Kohri K, Iguchi M, Kurita T (1990) Calcium urolithiasis and bone change. Nippon Hinyokika Gakkai Zasshi 81: 89PubMedGoogle Scholar
  36. 36.
    Kuczera M, Wiecek A, Kokot F (1993) Estimation of selected markers of bone metabolism in patients with nephrolithiasis. Pol Arch Med Wewn 89:385PubMedGoogle Scholar
  37. 37.
    Lauderdale DS, Thisted RA, Wen M, Favus MJ (2001) Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16: 1893PubMedGoogle Scholar
  38. 38.
    Lawoyin S, Sismilich S, Browne B, Pak CYC (1979) Bone mineral content in patients with calcium urolithiasis. Metabolism 28: 1250CrossRefPubMedGoogle Scholar
  39. 39.
    Lemann JJr, Litzow JR, Lennon EJ (1966) The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 45: 1608PubMedGoogle Scholar
  40. 40.
    Liberman UA, Sperling O, Atsmon A (1969) Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest 47: 2580Google Scholar
  41. 41.
    Lindergard B, Colleen S, Mansson W, Rademark C, Rogland B (1983) Calcium loading test and bone disease in patients with urolithiasis. Proc EDTA 20: 460Google Scholar
  42. 42.
    Maierhofer WF, Gray RW, Cheung HS, Lemann J (1984) Dietary calcium and serum 1,25(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int 26: 752PubMedGoogle Scholar
  43. 43.
    Mallette LE, Bilezikian JP, Heath H, Auerbach GD (1974) Primary hyperparathyroidism: clinical and biochemical features. Medicine 53: 127PubMedGoogle Scholar
  44. 44.
    Malluche HH, Tschope W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50: 654PubMedGoogle Scholar
  45. 45.
    Malvasi L, Sartori I, Giannini S, Al Awady M, Musaio F, Varotto S, D’Angelo A (1988) Mineral metabolism and bone mineral content in calcium nephrolithiasis with and without hyperparathyroidism. Urol Res 16: 190Google Scholar
  46. 46.
    Martin P, Bergmann P, Gillet C (1986) Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146: 689CrossRefPubMedGoogle Scholar
  47. 47.
    Maruyama Y, Hirata N, Yamada H, Sasaki K, Motomiya Y, Hirao Y, Okajima E (1993) A study on markers of bone metabolism in patients with non hypercalciuric calcium stone: measurement of gamma-carboxyglutamic acid and hydroxyproline. Nippon Hinyokika Gakkai Zasshi 84: 541PubMedGoogle Scholar
  48. 48.
    Melton LJ III, Crowson CS, Khosla S, Wolson DM, O’Fallon WM (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53: 459CrossRefPubMedGoogle Scholar
  49. 49.
    Messa P, Mioni G, Montanaro D, Adorati M, Antonucci F, Favazza A, Messa A, Enzmann G, Paganin L, Nardini R (1987) About a primitive osseous origin of the so-called “renal hypercalciuria”. Contr Nephrol 58: 106Google Scholar
  50. 50.
    Minisola S, Rosso R, Romagnoli E, Pacitti MT, Scarnecchia L, Carnevale V, Mazzuoli G (1993) Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 20: 113PubMedGoogle Scholar
  51. 51.
    Muldowney FP, Freaney R, Moloney MF (1982) Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 22: 292PubMedGoogle Scholar
  52. 52.
    Netelenbos JC, Jongen MJM, Van der Vijgh WJF, Lips P, Van Ginkel FC (1985) Vitamin D status in urinary calcium stone formation. Arch Intern Med 145: 681CrossRefPubMedGoogle Scholar
  53. 53.
    Nordin BEC, Peacock M, Wilkinson R (1972) Hypercalciuria and calcium stone disease. Clin Endocrinol Metab J 1: 169Google Scholar
  54. 54.
    Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg (1993) Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism. Urol Res 21: 169CrossRefPubMedGoogle Scholar
  55. 55.
    Pacifici R, Rothstein M, Rifas L, Lau KHW, Baylink DG, Avioli LV, Hruska K (1990) Increased monocyte interleukin-I activity and decreased vertebral bone density in patients with fasting hypercalciuria. J Clin Endocrinol Metab 71: 138PubMedGoogle Scholar
  56. 56.
    Pak CYC, Kaplan R, Bone H, Towsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciuria. N Engl J Med 292: 497PubMedGoogle Scholar
  57. 57.
    Pak CYC, Nicar MJ, Peterson R, Zerwekh JE, Snyder W (1981) Lack of unique pathophysiologic background for nephrolithiasis in primary hyperparathyroidism. J Clin Endocrinol Metab 53: 536PubMedGoogle Scholar
  58. 58.
    Peacock M (1975) Renal stone disease in primary hyperparathyroidism and their relationship to the action of PTH on calcium absorption. In: Talmadge R (ed) Calcium regulating hormones. Excerpta Medica, Amsterdam, p 78Google Scholar
  59. 59.
    Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7: 1383PubMedGoogle Scholar
  60. 60.
    Pines KL, Mudge GH (1951) Renal tubular acidosis with osteomalacia. Am J Med 11: 302CrossRefPubMedGoogle Scholar
  61. 61.
    Rao PN, Blacklock NJ (1983) A non-steroidal anti-inflammatory drug (flubiprofen) to control idiopathic hypercalciuria resistant to dietary manipulation. Br J Urol 55: 599PubMedGoogle Scholar
  62. 62.
    Rao DS, Wilson RJ, Kleerkoper M et al. (1988) Lack of biochemical progression of continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for a biphasic course. J Clin Endocrinol Metab 67: 1294PubMedGoogle Scholar
  63. 63.
    Rico H, Paramo P, Perez del Molino J, Nacarino L, Yague M (1988) Osteocalcin, parathormone and hypercalciuria. Eur Urol 15: 239PubMedGoogle Scholar
  64. 64.
    Riggs BL, Wahner HW, Dunn WL, Mazess PB, Offord KP, Melton L (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with ageing. J Clin Invest 67: 328PubMedGoogle Scholar
  65. 65.
    Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR (1977) Increased serum 1,25-dihydroxy vitamin D in idiopathic hypercalciuria. J Lab Clin Med 6: 955Google Scholar
  66. 66.
    Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bliezikian JP (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89: 327CrossRefPubMedGoogle Scholar
  67. 67.
    Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson (1998) Prevalence of renal stones in a population-based study of dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147: 914PubMedGoogle Scholar
  68. 68.
    Sperling O, Weinberger A, Oliver I, Liberman UA, De Vries A (1974) Hypouricemia, hypercalciuria and decreased bone density. A hereditary syndrome. Ann Intern Med 80: 482PubMedGoogle Scholar
  69. 69.
    Steiniche T, Mosekilde L, Christensen MS, Melsen F (1989) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 4: 309Google Scholar
  70. 70.
    Sutton RAL, Walker VR (1986) Bone resorption and hypercalciuria in calcium stone-formers. Metabolism 35: 485CrossRefPubMedGoogle Scholar
  71. 71.
    Takeda M, Katayama Y, Go H, Wakatsuki S, Kawasaki T, Sato S, Odano I (1991) Bone mineral densitometry by dual photon absorptiometry in patients with urolithiasis: on the possibility of the differential diagnosis of idiopathic hypercalciuria. Nippon Hinoyokika Gakkai Zasshi 82: 1954Google Scholar
  72. 72.
    Taylor AK, Lenken SA, Libanati C, Baylink DJ (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 20: 589PubMedGoogle Scholar
  73. 73.
    Thomsen K, Gotfredsen A, Christiansen C (1986) Is postmenopausal bone loss an age-related phenomenon? Calcif Tissue Int 39: 123PubMedGoogle Scholar
  74. 74.
    Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh A, Cohen N, Edelstein S, Liberman U (1987) Idiopathic hypercalciuria and hereditary hypophosphatemic rickets. N Engl J Med 316: 125PubMedGoogle Scholar
  75. 75.
    Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E (1998) A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 159: 654CrossRefPubMedGoogle Scholar
  76. 76.
    Trinchieri A, Zanetti G, Currò A, Lizzano R (2001) Effect of potential renal acid load of foods on calcium metabolism of renal calcium stone formers. Eur Urol 39 [Suppl 2]: 33Google Scholar
  77. 77.
    Velentzas C, Oreopoulos DG, Meema S, Meema HE, Nutsuga T, Alison E, Katirtzoglou A, Crassweller P (1981) Dietary calcium restriction may be good for patients’ stones but not for their bones. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis clinical and basic research. Plenum Press, New York. p 847Google Scholar
  78. 78.
    Weisenberg JR, Alonzo E, Bellorinfont E, Blasini AM, Rodriguez MA, Pazmartinez V, Martinis R (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49: 244PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Urology UnitOspedale A. Manzoni

Personalised recommendations